Dr. Manmeet Kaur Gujral, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $755.89 | 37 | 95.0% |
| Education | $40.00 | 2 | 5.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $383.13 | 18 | $0 (2024) |
| Genentech USA, Inc. | $183.70 | 10 | $0 (2023) |
| CSL Behring | $109.39 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $48.33 | 2 | $0 (2023) |
| GENZYME CORPORATION | $40.81 | 2 | $0 (2021) |
| Chiesi USA, Inc. | $16.86 | 1 | $0 (2024) |
| Amgen Inc. | $13.67 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $193.40 | 9 | CSL Behring ($87.29) |
| 2023 | $106.88 | 5 | Genentech USA, Inc. ($59.78) |
| 2022 | $61.21 | 3 | Genentech USA, Inc. ($37.88) |
| 2021 | $81.27 | 4 | Genentech USA, Inc. ($40.74) |
| 2020 | $50.01 | 2 | GlaxoSmithKline, LLC. ($34.17) |
| 2019 | $218.64 | 12 | GlaxoSmithKline, LLC. ($179.92) |
| 2018 | $84.48 | 4 | GlaxoSmithKline, LLC. ($65.96) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Inflammation | ||||||
| 09/28/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: IMMUNOLOGY | ||||||
| 07/02/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: IMMUNOLOGY | ||||||
| 04/26/2024 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 04/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $34.15 | General |
| Category: IMMUNOLOGY | ||||||
| 04/12/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $16.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/28/2024 | CSL Behring | Kcentra (Biological) | Education | In-kind items and services | $20.00 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 02/15/2024 | CSL Behring | Kcentra (Biological) | Education | In-kind items and services | $20.00 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 02/15/2024 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 10/26/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 05/19/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Respiratory | ||||||
| 05/09/2023 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Immunology | ||||||
| 02/15/2023 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Immunology | ||||||
| 01/11/2023 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Immunology | ||||||
| 10/28/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Respiratory | ||||||
| 07/08/2022 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $18.79 | General |
| 05/26/2022 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $19.09 | General |
| 12/03/2021 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $24.11 | General |
| 09/02/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Immunology | ||||||
| 07/29/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: IMMUNOLOGY | ||||||
| 04/23/2021 | Genentech USA, Inc. | Xolair (Biological), Esbriet | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Immunology | ||||||
| 12/02/2020 | Genentech USA, Inc. | Xolair (Biological), Esbriet | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Immunology | ||||||
| 03/06/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $34.17 | General |
| Category: RESPIRATORY | ||||||
| 12/20/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $32.56 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 66 | 105 | $48,529 | $14,364 |
| 2022 | 3 | 75 | 107 | $48,291 | $11,672 |
| 2021 | 3 | 65 | 97 | $58,201 | $11,919 |
| 2020 | 5 | 108 | 148 | $83,610 | $15,623 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 31 | 54 | $35,198 | $10,743 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 20 | 28 | $7,960 | $1,955 | 24.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 23 | $5,371 | $1,666 | 31.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 31 | 35 | $31,083 | $6,688 | 21.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 45 | $9,405 | $3,077 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 24 | 27 | $7,803 | $1,908 | 24.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 16 | 24 | $36,248 | $4,615 | 12.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 19 | 36 | $11,139 | $3,939 | 35.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 30 | 37 | $10,814 | $3,366 | 31.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 27 | 38 | $52,928 | $7,519 | 14.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 26 | 44 | $16,063 | $4,418 | 27.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 19 | 28 | $7,138 | $1,829 | 25.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 20 | 21 | $4,881 | $1,164 | 23.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 16 | 17 | $2,601 | $692.55 | 26.6% |
About Dr. Manmeet Kaur Gujral, M.D
Dr. Manmeet Kaur Gujral, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/13/2011. The National Provider Identifier (NPI) number assigned to this provider is 1891090353.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manmeet Kaur Gujral, M.D has received a total of $795.89 in payments from pharmaceutical and medical device companies, with $193.40 received in 2024. These payments were reported across 39 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($755.89).
As a Medicare-enrolled provider, Gujral has provided services to 314 Medicare beneficiaries, totaling 457 services with total Medicare billing of $53,578. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Location Bronx, NY
- Active Since 01/13/2011
- Last Updated 06/30/2016
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891090353
Products in Payments
- NUCALA (Biological) $365.87
- Xolair (Biological) $121.71
- Kcentra (Biological) $109.39
- FASENRA (Biological) $48.33
- DUPIXENT (Drug) $27.78
- ANORO (Drug) $17.26
- CLEVIPREX (Drug) $16.86
- TEZSPIRE (Biological) $13.67
- DUPIXENT (Biological) $13.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Bronx
Dr. David Altschul, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $394,687
Edvard Skripochnik, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $127,559
Dr. Cynthia Armand
Student in an Organized Health Care Education/Training Program — Payments: $68,024
Dr. Eric Woods, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $40,336
Ms. Kavita Gupta, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $31,772
Dr. Dmitriy Nevelev, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $30,107